96. Rossowski WJ, Zacharia S, Mungan Z, Ozmen V, Ertan A,
Baylor LM, Jiang NY, Coy D: Reduced gastric acid inhibitory effect
of pGlP(1-30)NH2 fragment with potent pancreatic amylase inhibitory
activity. Regulatory Peptides, 39:9-17, 1992.
* 98. Lopez J, Wright JA, Hammer, RA, Ertan
A: Chronic pancreatitis is associated with a high prevalence
of Giardiasis. Can J Gastroenterol,6(2):73-76, 1992.
Hammer RA, Ochoa A, Fernandez C, Ertan A, Arimura A: Somatostatin
as a mediator of the effect of neurotensin on pentagastrin - stimulated
acid secretion in rats. Peptides, 13:1175-1179, 1992.
*122. Younes M, Lechago J, Ertan A: Photodynamic therapy and genetic abnormalities. Gastroenterology, 120: 1065-6, 2001 (LTE).
*123. Ertan A: Treatment of gallstones by extracorporeal shock wave lithotripsy. Am J Gastroenterol, 97: 831-2, 2002.
*124. Dural TA, Ertan A: Endoscopic retrieval of proximally migrated dorsal pancreatic duct stent in a patient with pancreas divisium. Med Sci, 3:65-17, 2002
*125. Carlson N, Lechago J, Richter J, Sampliner RE, Peterson L, Santella RM, Goldsblum JR, Falk GW, Ertan A, Younes M: Acid supression therapy may not alter malignant progression in Barrett's metaplasia showing p53 protein accumulation. Am J Gastroenterol, 97: 1340 - 5, 2002.
*126. Younes M, Henson DE, Ertan A, Miller CC: Incidence and survival trends of esophageal carcinoma in the United States. Racial and gender differences by histological type. Scand J Gastroenterol, 37:1359-65, 2002.
*127. Liu L, Ergun G, Ertan A, et al: Detection of oxidative DNA damage in esophageal biopsies of patients with reflux symptoms and normal pH Monitoring. Aliment Pharmacol. Ther, 18: 693-8, 2003
*128. Younes M, Ertan A, Lechago J: p53 protein anad malignant progression in Barrett's metaplasia. Am J Gastroenterol, 95: 1200-1, 2003 (LTE).
*129 Gonlusen, G., Akgun H, Ertan A, et al: Renal failure and nephrocalcinosis associated with oral phosphate bowel cleansing--Clinicial patterns and renal biopsy findings. Arch Pathol Lab Med, 129: 71-76, 2005.
*130. Chen X, Lechago J, Ertan A, et al.: Expression of the high mobility group proteins HMGI(Y) correlates with malignant progression in Barrett's Metaplaisa. Cancer Epidemiology, Biomarkers and Prevention, 2003 (in press).
*131. Ertan A, Botoman VA: International gastroenterology and American College of Gastroenterology. Am J. Gastroenterol, 2006 (in press).
*132. Shannon G. Ertan A, Qureshi W, Fife C: Hyperbaric oxygen therapy for pneumatosis coli. Dig Dis Sci, 2002 (in press).
*133 Younes, M, Ertan A, Ergun G, etal: Goblet cell mimickers in esophageal biopsies are not associated with an increased risk of dysplasia. Arch Path Lab Med, 2006 (in press).
*134 Amrikachi M, Ertan A, Schwartz MR: Value of colorectal biopsies with chronic diarrhea and normal endosocpic findings. Gastrointest Endosc, 2006 (in press).
Please download Dr. Ertan's CV for up-to-date publications.